Home / Central Data Catalog / FRESH-PEF153-EN
central

European observational study on epileptic patients (Requiring at least two Antiepileptic drugs)

France, Spain, 2010 - 2011
Reference ID
FRESH-PEF153-en
Producer(s)
Christel;LECLERC-ZWIRN
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
38
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Data Access
  • Contacts

    • Identification

    Survey ID number

    FRESH-PEF153-en
    Title

    European observational study on epileptic patients (Requiring at least two Antiepileptic drugs)
    Abbreviation or Acronym

    ESPERA
    Country
    Name Country code
    France fr
    Spain es
    Kind of Data

    ['Clinical data','Participant-reported health data']
    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    Neurology health theme
    Healthcare system determinants: Use of care health determinant
    Healthcare system determinants health determinant
    Keywords
    pharmaco-resistance observational

    Coverage

    Universe

    {"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"• Patient aged ≥ 18 years, presenting with focal epilepsy with or without secondary generalization; • Patient currently treated with at least 2 antiepileptic medications in association, for at least 3 months, whether the patient is seizure-free or not; • Available medical data allowing to specify AEDs responsiveness status (resistant, responsive, or undefined); • Patient who has agreed to participate after having read the information letter.","clusion_E":""}

    Producers and sponsors

    Primary investigators
    Name
    Christel;LECLERC-ZWIRN
    Producers
    Name Role
    GLAXOSMITHKLINE (FRANCE) sponsor
    Funding Agency/Sponsor
    Name
    GLAXOSMITHKLINE (FRANCE)

    Study authorization

    Agency
    Agency name
    CNIL

    Sampling

    Sample frame

    Unit Type

    ['Through organizations (health services or institutions, schools, businesses, etc.)','Through independent healthcare practitioners']
    Sampling Procedure

    ['{"concept":{"vocabURI":"Probability.Stratified","vocab":"CESSDA"},"value":"Probability: Stratified"}']

    Survey instrument

    Questionnaires

    Access on specific project only
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2010-01-01 2011-01-01
    Time Method

    One-time cross-sectional study
    Mode of data collection
    • {"concept":{"vocabURI":"SelfAdministeredQuestionnaire","vocab":"CESSDA"},"value":"Self-administered questionnaire"}
    • {"concept":{"vocabURI":"Interview","vocab":"CESSDA"},"value":"Interview with the participant (including clinical)"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Health event/morbidity Health care consumption and services Quality of life/health perception

    Data Access

    Availability Status

    {"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}

    Contacts

    Contacts
    Name Email
    Christel;LECLERC-ZWIRN christel.c.leclerc-zwirn@gsk.com
    Back to Catalog